Page last updated: 2024-10-30

lomustine and Heart Diseases

lomustine has been researched along with Heart Diseases in 3 studies

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research Excerpts

ExcerptRelevanceReference
" Hence, inhibitors of the TGF-β signaling pathway require a careful identification of a safe therapeutic window and a comprehensive monitoring of the cardiovascular system."2.80Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study. ( Azaro, A; Baselga, J; Carducci, M; Cleverly, AL; Corretti, M; Dolan, M; Fernández, MS; Gueorguieva, I; Kovacs, RJ; Lahn, MM; Maldonado, G; Pillay, NS; Romero, FL; Sepulveda-Sánchez, JM, 2015)
"Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual."1.27Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kovacs, RJ1
Maldonado, G1
Azaro, A1
Fernández, MS1
Romero, FL1
Sepulveda-Sánchez, JM1
Corretti, M1
Carducci, M1
Dolan, M1
Gueorguieva, I1
Cleverly, AL1
Pillay, NS1
Baselga, J1
Lahn, MM1
Harker, WG1
Kushlan, P1
Rosenberg, SA1
Chahinian, AP1
Mandel, EM1
Holland, JF1
Jaffrey, IS1
Teirstein, AS1

Trials

1 trial available for lomustine and Heart Diseases

ArticleYear
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study.
    Cardiovascular toxicology, 2015, Volume: 15, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Pressure; Echocardiog

2015

Other Studies

2 other studies available for lomustine and Heart Diseases

ArticleYear
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
    Annals of internal medicine, 1984, Volume: 101, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1984
MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
    Cancer, 1979, Volume: 43, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell;

1979
chemdatabank.com